Titre : Fidji

Fidji : Questions médicales fréquentes

Termes MeSH sélectionnés :

Lymphocyte Function-Associated Antigen-1
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Fidji : Questions médicales les plus fréquentes", "headline": "Fidji : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Fidji : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-08", "dateModified": "2025-05-03", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Fidji" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Mélanésie", "url": "https://questionsmedicales.fr/mesh/D008542", "about": { "@type": "MedicalCondition", "name": "Mélanésie", "code": { "@type": "MedicalCode", "code": "D008542", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "Z01.639.760.590" } } }, "about": { "@type": "MedicalCondition", "name": "Fidji", "alternateName": "Fiji", "code": { "@type": "MedicalCode", "code": "D005367", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Mike Kama", "url": "https://questionsmedicales.fr/author/Mike%20Kama", "affiliation": { "@type": "Organization", "name": "Ministry of Health and Medical Services, Suva, Fiji." } }, { "@type": "Person", "name": "Masoud Mohammadnezhad", "url": "https://questionsmedicales.fr/author/Masoud%20Mohammadnezhad", "affiliation": { "@type": "Organization", "name": "School of Public Health and Primary Care, College of Medicine, Nursing and Health Science, Fiji National University, Suva, Fiji." } }, { "@type": "Person", "name": "Eric Rafai", "url": "https://questionsmedicales.fr/author/Eric%20Rafai", "affiliation": { "@type": "Organization", "name": "Ministry of Health and Medical Services, Suva, Fiji." } }, { "@type": "Person", "name": "Aalisha Sahukhan", "url": "https://questionsmedicales.fr/author/Aalisha%20Sahukhan", "affiliation": { "@type": "Organization", "name": "Ministry of Health and Medical Services, Suva, Fiji." } }, { "@type": "Person", "name": "Colleen L Lau", "url": "https://questionsmedicales.fr/author/Colleen%20L%20Lau", "affiliation": { "@type": "Organization", "name": "" } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Impact of the cytotoxic T-lymphocyte associated antigen-4 rs231775 A/G polymorphism on cancer risk.", "datePublished": "2023-12-03", "url": "https://questionsmedicales.fr/article/38144286", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.heliyon.2023.e23164" } }, { "@type": "ScholarlyArticle", "name": "Nitidine chloride regulates cell function of bladder cancer in vitro through downregulating Lymphocyte antigen 75.", "datePublished": "2023-03-14", "url": "https://questionsmedicales.fr/article/36914902", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00210-023-02446-0" } }, { "@type": "ScholarlyArticle", "name": "Relationship Between Cytotoxic T-Lymphocyte-Associated Antigen-4: Programmed Death-1 Genes Polymorphisms and Susceptibility to Pediatric B-Cell Acute Lymphoblastic Leukemia.", "datePublished": "2024-06-28", "url": "https://questionsmedicales.fr/article/38940594", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/MPH.0000000000002909" } }, { "@type": "ScholarlyArticle", "name": "Tumor-associated macrophages regulate the function of cytotoxic T lymphocyte through PD-1/PD-L1 pathway in multiple myeloma.", "datePublished": "2022-05-20", "url": "https://questionsmedicales.fr/article/35593325", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/cam4.4814" } }, { "@type": "ScholarlyArticle", "name": "Blockade of TIM-3 and PD-1 enhances the antitumor effects of MAGE-A11 antigen-specific cytotoxic T lymphocytes.", "datePublished": "2022-06-14", "url": "https://questionsmedicales.fr/article/35710477", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.bulcan.2022.04.005" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Régions géographiques", "item": "https://questionsmedicales.fr/mesh/D005842" }, { "@type": "ListItem", "position": 3, "name": "Iles", "item": "https://questionsmedicales.fr/mesh/D062312" }, { "@type": "ListItem", "position": 4, "name": "Mélanésie", "item": "https://questionsmedicales.fr/mesh/D008542" }, { "@type": "ListItem", "position": 5, "name": "Fidji", "item": "https://questionsmedicales.fr/mesh/D005367" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Fidji - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Fidji", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-15", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Fidji", "description": "Comment diagnostiquer la dengue aux Fidji ?\nQuels tests pour le paludisme aux Fidji ?\nComment identifier une infection à leptospirose ?\nQuels signes indiquent une infection virale ?\nComment diagnostiquer une maladie tropicale ?", "url": "https://questionsmedicales.fr/mesh/D005367?mesh_terms=Lymphocyte+Function-Associated+Antigen-1&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Fidji", "description": "Quels sont les symptômes de la dengue ?\nQuels signes de paludisme aux Fidji ?\nQuels symptômes de leptospirose ?\nComment reconnaître une infection virale ?\nQuels symptômes d'une maladie tropicale ?", "url": "https://questionsmedicales.fr/mesh/D005367?mesh_terms=Lymphocyte+Function-Associated+Antigen-1&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Fidji", "description": "Comment prévenir la dengue ?\nQuelles mesures pour éviter le paludisme ?\nComment prévenir la leptospirose ?\nQuelles précautions pour les infections virales ?\nComment prévenir les maladies tropicales ?", "url": "https://questionsmedicales.fr/mesh/D005367?mesh_terms=Lymphocyte+Function-Associated+Antigen-1&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Fidji", "description": "Quel traitement pour la dengue ?\nComment traiter le paludisme ?\nQuel traitement pour la leptospirose ?\nComment gérer une infection virale ?\nQuels traitements pour les maladies tropicales ?", "url": "https://questionsmedicales.fr/mesh/D005367?mesh_terms=Lymphocyte+Function-Associated+Antigen-1&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Fidji", "description": "Quelles complications de la dengue ?\nQuelles complications du paludisme ?\nQuelles complications de la leptospirose ?\nQuelles complications des infections virales ?\nQuelles complications des maladies tropicales ?", "url": "https://questionsmedicales.fr/mesh/D005367?mesh_terms=Lymphocyte+Function-Associated+Antigen-1&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Fidji", "description": "Quels sont les facteurs de risque pour la dengue ?\nQuels facteurs de risque pour le paludisme ?\nQuels facteurs de risque pour la leptospirose ?\nQuels facteurs de risque pour les infections virales ?\nQuels facteurs de risque pour les maladies tropicales ?", "url": "https://questionsmedicales.fr/mesh/D005367?mesh_terms=Lymphocyte+Function-Associated+Antigen-1&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer la dengue aux Fidji ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur des tests sanguins pour détecter les anticorps ou le virus." } }, { "@type": "Question", "name": "Quels tests pour le paludisme aux Fidji ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests sanguins, comme le frottis sanguin ou le test de diagnostic rapide, sont utilisés." } }, { "@type": "Question", "name": "Comment identifier une infection à leptospirose ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Un diagnostic est établi par des tests sérologiques ou PCR sur des échantillons de sang." } }, { "@type": "Question", "name": "Quels signes indiquent une infection virale ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Fièvre, éruption cutanée et douleurs musculaires sont des signes courants d'infections virales." } }, { "@type": "Question", "name": "Comment diagnostiquer une maladie tropicale ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Un historique médical et des tests spécifiques sont nécessaires pour diagnostiquer ces maladies." } }, { "@type": "Question", "name": "Quels sont les symptômes de la dengue ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Fièvre, douleurs articulaires, éruptions cutanées et fatigue sont fréquents." } }, { "@type": "Question", "name": "Quels signes de paludisme aux Fidji ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Fièvre, frissons, sueurs, et douleurs corporelles sont des symptômes typiques." } }, { "@type": "Question", "name": "Quels symptômes de leptospirose ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Fièvre, maux de tête, douleurs musculaires et éruptions cutanées peuvent apparaître." } }, { "@type": "Question", "name": "Comment reconnaître une infection virale ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Symptômes comme fièvre, fatigue, et douleurs musculaires sont souvent présents." } }, { "@type": "Question", "name": "Quels symptômes d'une maladie tropicale ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes varient, mais incluent souvent fièvre, éruptions cutanées et douleurs." } }, { "@type": "Question", "name": "Comment prévenir la dengue ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Éliminer les eaux stagnantes et utiliser des répulsifs contre les moustiques." } }, { "@type": "Question", "name": "Quelles mesures pour éviter le paludisme ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Utiliser des moustiquaires, des répulsifs et prendre des médicaments préventifs." } }, { "@type": "Question", "name": "Comment prévenir la leptospirose ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Éviter le contact avec des eaux potentiellement contaminées et porter des bottes." } }, { "@type": "Question", "name": "Quelles précautions pour les infections virales ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Se laver les mains régulièrement et éviter les contacts étroits avec les malades." } }, { "@type": "Question", "name": "Comment prévenir les maladies tropicales ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Éducation sur les risques, vaccination et mesures d'hygiène sont essentielles." } }, { "@type": "Question", "name": "Quel traitement pour la dengue ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement est symptomatique, avec des analgésiques et une hydratation adéquate." } }, { "@type": "Question", "name": "Comment traiter le paludisme ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Des médicaments antipaludiques comme la chloroquine sont utilisés selon le type." } }, { "@type": "Question", "name": "Quel traitement pour la leptospirose ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Les antibiotiques comme la doxycycline sont prescrits pour traiter l'infection." } }, { "@type": "Question", "name": "Comment gérer une infection virale ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement est généralement symptomatique, avec repos et hydratation." } }, { "@type": "Question", "name": "Quels traitements pour les maladies tropicales ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement dépend de la maladie, souvent avec des médicaments spécifiques." } }, { "@type": "Question", "name": "Quelles complications de la dengue ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications peuvent inclure la dengue sévère, entraînant des hémorragies." } }, { "@type": "Question", "name": "Quelles complications du paludisme ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Le paludisme peut causer des anémies sévères et des défaillances organiques." } }, { "@type": "Question", "name": "Quelles complications de la leptospirose ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Des complications rénales, hépatiques et respiratoires peuvent survenir." } }, { "@type": "Question", "name": "Quelles complications des infections virales ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Certaines infections peuvent entraîner des complications neurologiques ou respiratoires." } }, { "@type": "Question", "name": "Quelles complications des maladies tropicales ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Les complications varient selon la maladie, pouvant inclure des défaillances organiques." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque pour la dengue ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Vivre dans des zones à forte densité de moustiques et avoir un accès limité à l'eau." } }, { "@type": "Question", "name": "Quels facteurs de risque pour le paludisme ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Vivre dans des zones endémiques et ne pas utiliser de protection contre les moustiques." } }, { "@type": "Question", "name": "Quels facteurs de risque pour la leptospirose ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Exposition à des eaux contaminées et travail dans l'agriculture ou l'élevage." } }, { "@type": "Question", "name": "Quels facteurs de risque pour les infections virales ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Un système immunitaire affaibli et le contact avec des personnes infectées augmentent le risque." } }, { "@type": "Question", "name": "Quels facteurs de risque pour les maladies tropicales ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Voyager dans des zones endémiques et avoir un accès limité aux soins de santé sont des risques." } } ] } ] }

Sources (10000 au total)

Impact of the cytotoxic T-lymphocyte associated antigen-4 rs231775 A/G polymorphism on cancer risk.

Cytotoxic T-lymphocyte associated antigen-4 (CTLA-4) is an immunosuppressive checkpoint that is involved in the development and metastasis of cancers. Several studies revealed that CTLA-4 rs231775A/G ... We conducted a pooled analysis with eligible studies to explore the association between the CTLA-4 rs231775 variant and cancer risk. Additionally, we used... In total, 92 case-control studies involving 29,987 patients with cancer and 36,484 healthy individuals (controls) were included in the pooled analysis. In the stratified analysis based on cancer type,... The CTLA-4 rs231775 A/G polymorphism is associated with cancer risk in East Asian population. This polymorphism is especially associated with BLCA....

Tumor-associated macrophages regulate the function of cytotoxic T lymphocyte through PD-1/PD-L1 pathway in multiple myeloma.

Tumor-associated macrophages (TAMs) are originated from circulating mononuclear cells in peripheral blood. They result from the recruitment of tumor cells and are a vital constituent of the tumor micr... From March 2020 to January 2021, 28 healthy controls (HC) and 86 multiple myeloma (MM) (53 newly diagnosed MM [NDMM] and 33 remissions) patients were enrolled as objects of the study. The expression o... The percentage of TAMs in NDMM group (61.49 ± 2.176%) increased when compared with remission (23.08 ± 1.699%, p < 0.001) and HC group (17.95 ± 1.865%, p < 0.001), and TAMs decreased after adding CSF1R... Our study shows that TAMs were increased in MM patients which can inhibit the function of cytotoxic T lymphocyte (CTL) through the PD-1/ PD-L1 signaling pathway and participate in the occurrence of im...

Expression of cytotoxic T lymphocyte-associated antigen 4, CD44, and E-cadherin in the microenvironment of breast carcinomas.

The expression of cytotoxic T lymphocyte-associated antigen 4, E-cadherin, and CD44 in the area of tumor budding was investigated in breast carcinomas in our study.... Tumor budding was counted at the invasive margins in 179 breast carcinomas. To understand the microenvironment of tumor budding, we examined the expression status of the immune checkpoint molecules su... Tumors were separated into low (≤5) and high tumor budding groups (>5) based on the median budding number. Lymphovascular, perineural invasion, and the number of metastatic lymph nodes were significan... Tumor budding could predict poor prognosis in breast carcinomas, and anti-cytotoxic T lymphocyte-associated antigen 4 immunotherapies may be beneficial in patients with high tumor budding tumors....

Association of Cytotoxic T-Lymphocyte Antigen-4 Gene Polymorphism with Type 1 Diabetes Mellitus: In silico Analysis of Biological Features of CTLA-4 Protein on Ethiopian Population.

T1DM is a chronic organ-specific T-cell-mediated autoimmune disease characterized by the selective destruction of β-cells in the islets of Langerhans, resulting in insulin deficiency and hyperglycemia... The aim of the study was to investigate CTLA-4 exon 1 was linked to A49G polymorphism with T1DM and its biological features of CTLA-4 among T1DM patients, in Ethiopia.... A case-control study was done from December 2019 to March 2020 on 210 study participants (105 T1DM patients and 105 healthy controls). Polymerase Chain Reaction amplification with forward and reverse ... The CTLA-4 (+A49G) gene polymorphism was observed on 56 (26.7%) study participants, 39 (18.57%) of T1DM patients, and 17 (0.08%) were controls. In T1DM and controls, the frequency of the A allele was ... The study showed as CTLA-4 (+A49G) gene polymorphism is linked with T1DM in the Ethiopian population....

In pancreatic cancer patients, chemotherapy reshapes the gene expression profile and antigen receptor repertoire of T lymphocytes and enhances their effector response to tumor-associated antigens.

Pancreatic Ductal Adenocarcinoma (PDA) is one of the most aggressive malignancies with a 5-year survival rate of 13%. Less than 20% of patients have a resectable tumor at diagnosis due to the lack of ... Proliferation, and cytokine release and TCRB repertoire of from PDA patient peripheral T lymphocytes, before and after CT, were analyzed in vitro in response to four tumor-associated antigens (TAA), n... CT increased the number of TAA recognized by T lymphocytes, which positively correlated with patient survival, and high IFN-γ production TAA-induced responses were significantly increased after CT. We... These data suggest that the expression of fatty acid or IRAK1/IL1Rrelated genes predicts T lymphocyte effector or regulatory responses to TAA in patients that undergo CT. These findings are a springbo...